1. Academic Validation
  2. Two xanthones from Swertia punicea with hepatoprotective activities in vitro and in vivo

Two xanthones from Swertia punicea with hepatoprotective activities in vitro and in vivo

  • J Ethnopharmacol. 2014 May 14;153(3):854-63. doi: 10.1016/j.jep.2014.03.058.
Xi-Yuan Zheng 1 Ying-Fan Yang 1 Wan Li 1 Xin Zhao 2 Yi Sun 2 Hua Sun 3 Yue-Hua Wang 3 Xiao-Ping Pu 4
Affiliations

Affiliations

  • 1 National Key Research Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing 100191, PR China; Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University, Xueyuan Road 38, PR China.
  • 2 National Key Research Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing 100191, PR China.
  • 3 Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Xian Nong Tan Street 1, PR China.
  • 4 National Key Research Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing 100191, PR China. Electronic address: pxp2020@aliyun.com.
Abstract

Ethnopharmacological relevance: Swertia punicea Hemsl. (Gentianaceae) is more commonly known as "Ganyan-cao" and used mainly as a traditional Chinese folk medicine for the treatment of acute bilious hepatitis, cholecystitis, fever, intoxification and jaundice.

Materials and methods: The active hepatoprotective constituents of Swertia punicea were purified using various column chromatography techniques. The structures of two isolated compounds were determined on the basis of spectroscopic data interpretation such as NMR analysis. The hepatoprotective activities of isolated compounds were evaluated by using hepatotoxicity in vitro and dimethylnitrosamine-induced rat hepatic fibrosis in vivo, respectively.

Results: Two Xanthones, 1, 7-dihydroxy-3, 4, 8-trimethoxyxanthone (1) and bellidifolin (2) were isolated from the stems of Swertia punicea. The compounds 1 and 2 exhibited notable hepatoprotective activities against carbon tetrachloride (CCl4) -induced HepG2 cell damage, and effectively alleviated the levels of aspartate transaminase (AST), Lactate Dehydrogenase (LDH), superoxide dismutase (SOD) and malonic dialdehyde (MDA) induced by CCl₄ in a concentration-dependent manner. Co-treatment with compound 2 significantly increased the cell viability compared with N-acetyl-p-aminophenol (APAP) treatment. Compound 2 also alleviated APAP-induced hepatotoxicity by increasing glutathione (GSH) content and decreasing hydroxyl free radical (·OH) levels and reactive oxygen specises (ROS) production. In addition, the protective effect of compound 1 significantly alleviated DMN-induced liver inflammation and fibrosis. Oral administration of compound 1 recovered the reduction of albumin (ALB) and reversed the elevation of serum alanine transaminase (ALT), AST and total bilirubin (TBIL) in dimethylnitrosamine (DMN)-induced fibrotic rats. Severe oxidative stress induced in fibrotic rats was evidenced by a 1.5-fold elevation in MDA and a fall in the SOD activity, and treatment with compound 1 protected against these adverse effects. Recovery of rat liver tissue against DMN-induced hepatocellular necrosis, inflammatory changes and hepatic fibrosis by compound 1 is also confirmed by H&E and Masson stained histopathological evaluation of liver tissue.

Conclusion: Two Xanthones from Swertia punicea exhibited hepatoprotective activities in vitro (compounds 1 and 2) and in vivo (compound 1), respectively.

Keywords

Acetaminophen-induced hepatotoxicity; Bellidifolin (PubChem CID: 5281623); CCl(4)-induced hepatotoxicity; DMN-induced rat hepatic fibrosis; Hepatoprotective; Swertia punicea Hemsl; Xanthones.

Figures
Products